Granite Investment Partners’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,058
| Closed | -$15.7K | – | 271 |
|
|
2024
Q1 | $15.7K | Buy |
+1,058
| New | +$15.7K | ﹤0.01% | 256 |
|
|
2020
Q1 | – | Sell |
-1,430
| Closed | -$31K | – | 304 |
|
|
2019
Q4 | $31K | Sell |
1,430
-9,609
| -87% | -$208K | ﹤0.01% | 285 |
|
|
2019
Q3 | $206K | Buy |
11,039
+3,828
| +53% | +$71.4K | 0.01% | 320 |
|
|
2019
Q2 | $188K | Sell |
7,211
-6,333
| -47% | -$165K | 0.01% | 332 |
|
|
2019
Q1 | $348K | Buy |
13,544
+6,333
| +88% | +$163K | 0.02% | 320 |
|
|
2018
Q4 | $166K | Hold |
7,211
| – | – | 0.01% | 325 |
|
|
2018
Q3 | $231K | Buy |
+7,211
| New | +$231K | 0.01% | 295 |
|
|
2013
Q3 | – | Sell |
-10,614
| Closed | -$354K | – | 257 |
|
|
2013
Q2 | $354K | Buy |
+10,614
| New | +$354K | 0.06% | 194 |
|